The value of conventional asthma and COPD classifications has again been called into question as findings from a global real-world study show the labels do little to differentiate between clinically important phenotypes, potentially leading to unsuitable or unsafe treatment decisions. Respiratory clinicians involved in the Australian-led NOVELTY study say their analysis of baseline characterisers in ...
‘Oversimplified’ asthma and COPD classifications miss important subgroups: NOVELTY study
By Sunalie Silva
8 Jul 2021